A full Press Working Area will be available. The hours are:

Saturday 9 June, 12:00 - 20:30

• Sunday 10 June, 07:30 - 19:30
• Monday 11 June, 07:30 - 19:30
• Tuesday 12 June, 07:30 - 13:00

Information on the scientific session can be accessed here:

The Heart Failure 2007 Congress is organised by the Heart Failure Association of the European Society of Cardiology. Each year more than 3,500 experts in the field gather to discuss the latest discoveries in the field. There will be 57 scientific sessions, 14 satellite sessions, 6 moderated poster sessions, 4 poster sessions and 2 "Meet the Experts" sessions. More than 1,000 abstracts were submitted and 50% were accepted.

Highlighted presentations include:

Saturday 9 June

• Room 1: Opening Ceremony
• The HFA of the ESC Honorary Lecture: The future of Biomarkers in heart failure - E. Braunwald (US)

Sunday 10 June:

• Room 2 at 08.30
• "Biomarkers are better than clinicians in diagnosing heart failure: Pro. S.D.Anker (Berlin,DE) Con. I.S.Anand (Edina, US)

• Room 3 at 16.00
• The adult human atrium a realistic cell source for therapy" (P. Doevendans)
• The human testis a realistic cell source for therapy (G. Hasenfuss)

Monday 11 June:

• Room 1 at 08.30
• CRP and natriuretic peptides do they tell a different story" T.A. McDonagh (London, GB)

• Room 2 at 08.30
• Levosimendan is a first-line drug in the management of acute heart failure Pro: (F. Follath); Contra: (J. Cleland)
• BNP is an obligatory biomarker for long-term management of chronic heart failure Pro: (G. Jondeau); Contra: (J.J.V. McMurray)

• Room 1 at 11.00
• Haemodynamic monitoring: tool or toy" (G.S. Filippatos) '"/>